Please use this identifier to cite or link to this item: http://148.72.244.84:8080/xmlui/handle/xmlui/13920
Full metadata record
DC FieldValueLanguage
dc.contributor.authorFadhil Jasim-
dc.contributor.authorZuhair AA.Khammas-
dc.contributor.authorAshraf .S. AL-Ayash-
dc.date.accessioned2024-04-06T08:21:47Z-
dc.date.available2024-04-06T08:21:47Z-
dc.date.issued2005-
dc.identifier.citationhttps://alfatehjournal.uodiyala.edu.iq/index.php/jfathen_US
dc.identifier.issn1996-8752-
dc.identifier.urihttp://148.72.244.84:8080/xmlui/handle/xmlui/13920-
dc.description.abstractThe drug desferrioxamine mesylate (DFOM) forms with vanadium (v) a colored chelate (λ max = 460 nm) complex at pH – range (1- 1.34 ) which is extractable with Benzyl alcohol as organic solvent . Under the appropriate experimental conditions a calibration plot was set up from which some analytical parameters were derived and deduced by regression .Standard additions procedure was also adopted .It has been estimated that the concentration of the drug DFOM to be 487.6 mg per unit and 485.1 mg per unit for both calibrations. Under optimal conditions, the developed method has been achieved the following characteristics: LDR (2.0 – 275 μ g ml -1) DFOM, RSD % (0.3- 0.45), sandell sensitivity (0.158 μ g. cm-2), LOD (0.5 μ g ml -1), recovery %(101.466 ± 0.763), Erel %(1.466). stability constant ( 2.1x 107 M -1).The mole – ratio method ( 1:1) approved that DFOM V (v) as a structure of the complex. The developed procedure has been adapted to analyze DFOM in various pharmaceuticals .en_US
dc.language.isoenen_US
dc.publisherمجلة الفتح للبحوث التربوية والنفسيةen_US
dc.relation.ispartofseries9;2-
dc.titleSPECTROPHOTOMETRIC MICRO DETERMINATION OF DRUG DESFERRIOXAMINE IN SOME PHARMACEUTICALS BY CHELTATING WITH VANADIUM (V)en_US
dc.typeArticleen_US
Appears in Collections:مجلة الفتح / The Al-Fateh Journal for Educational and Psychological Research

Files in This Item:
File Description SizeFormat 
27.pdf167.03 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.